ClinicalTrials.gg
CompletedNCT07433140PROSTIMERSBOPUpdated Aug 3, 2026

Effect of Rectus Block Timing on Opioid Use

An interventional study of Early bilateral rectus sheat block and Late bilateral rectus sheat block in Prostate Cancer, Pain Management and Nociception Level Index(NoL), sponsored by Koc University Hospital. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-03.

Sponsored by Koc University Hospital · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 111 studies in Prostatic Neoplasms with a site in Turkey — 22 open to participants now, 42 under way, 21 of them phase 3. Prostatic Neoplasms · Turkey.

Enrollment
78th of 90
50 · median 226
Started
2026
with 12 others
No phase
40 of 111
6 open now
Registered
94th of 111
by date

Among the 111 studies in Prostatic Neoplasms with a site in Turkey, this one is the 78th largest by enrollment of the 90 interventional ones that give a count, is one of 13 that started in 2026, is one of 40 with no phase, and was the 94th registered.

Prostatic Neoplasms

7,058 studies on the registry are indexed under Prostatic Neoplasms; 1,582 are open to participants now.

Browse Prostatic Neoplasms studies →

Open to participants now

22 of the 111 studies in Prostatic Neoplasms with a site in Turkey are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,236 Prostatic Neoplasms studies recruiting now, 933 (75%) set no upper age limit and 77 (6%) stop at 75 or younger; 67 take children under 18; 82 take healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 111 studies in Prostatic Neoplasms with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to observe the effect of administering local anesthetic to the abdominal wall at the beginning or end of surgery under general anesthesia on opioid consumption during surgery. The hypothesis of this study is to demonstrate that administering a rectus sheath block before the surgical procedure under general anesthesia is effective in reducing intraoperative opioid consumption and opioid-related side effects compared to administering it after the surgery is completed.

03

Conditions studied

  • Prostate Cancer
  • Pain Management
  • Nociception Level Index(NoL)
  • Nociception Monitoring
  • Opioid Consumption

Browse trials for

Keywords

  • Robot Surgery
  • Rectus sheath block
  • Nociception
  • opioid
  • Cancer of Prostate
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-ASA () I-III adult patients with prostate cancer and benign prostate diseases scheduled for robotic surgery at Koç University Hospital.

Exclusion criteria

Exclusion Criteria:

  • \<18 years of age
  • ASA () IV, V patients
  • Non-elective emergency cases
  • Previous major abdominal/pelvic surgery
  • History of significant psychiatric disorders
  • Patients who may have to nerve blocks (bleeding diathesis, infection, and local anesthetic allergy).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
50 participants (actual)

Study arms

  • Active comparator
    Preoperative RSB Group

    The group of patients undergoing robotic prostatectomy surgery who received a rectus sheath block prior to the surgical procedure

    Procedure: Early bilateral rectus sheat block

  • Active comparator
    Postoperative RSB Group

    The group of patients undergoing robotic prostatectomy surgery who received a rectus sheath block after the surgical procedure

    Procedure: Late bilateral rectus sheat block

Interventions

  • ProcedureEarly bilateral rectus sheat block

    Bilateral rectus sheat block will be performed after the anesthesia induction, before the start of the surgery

  • ProcedureLate bilateral rectus sheat block

    Bilateral rectus sheat block will be performed after the completion of the surgery, before the end of general anesthesia

06

What researchers measure

Primary outcomes

  1. Total intraoperatif remifentanil consumption

    Time frame: Total operative duration

  2. Average intraoperative remifentanil consumption

    Total intraoperative remifentail consumption divided by the weight of the patient (kg) and total operative duration (minutes). (mcg/kg/dk)

    Time frame: Total operative duration

Secondary outcomes

  1. Cumulative opioid consumption at postoperative 1st hour

    Cumulative opioid consumption at postoperative 1st hour in IV morphine equivalent

    Time frame: From the end of the surgery to the end of the first postoperative hour

  2. Cumulative opioid consumption at postoperative 6th hour

    Cumulative opioid consumption at postoperative 6th hour in IV morphine equivalent

    Time frame: From the end of the surgery to the end of the 6th postoperative hour

  3. Cumulative opioid consumption at postoperative 12th hour

    Cumulative opioid consumption at postoperative 12th hour in IV morphine equivalent

    Time frame: From the end of the surgery to the end of the 12th postoperative hour

  4. Cumulative opioid consumption at postoperative 24th hour

    Cumulative opioid consumption at postoperative 24th hour in IV morphine equivalent

    Time frame: From the end of the surgery to the end of the 24th postoperative hour

  5. Pain at postoperative first hour

    Pain measured by Numeric Rating Scale (0-10)

    Time frame: At the end of the postoperative 1st hour

  6. Pain at postoperative 6th hour

    Pain measured by Numeric Rating Scale (0-10)

    Time frame: At the end of the postoperative 6th hour

  7. Pain at postoperative 12th hour

    Pain measured by Numeric Rating Scale (0-10)

    Time frame: At the end of the postoperative 12th hour

  8. Pain at postoperative f24th hour

    Pain measured by Numeric Rating Scale (0-10)

    Time frame: At the end of the postoperative 24th hour

  9. Rescue analgesia

    Total rescue fentanyl administered (mcg)

    Time frame: From the end of the surgery to the end of the first postoperative hour

  10. Patient satisfaction

    Patient satisfaction reported by the patient in a scale from 1 to 5

    Time frame: At the end of the 24th postoperative hour

07

Study locations

1 site
  • Koc University Hospital
    Istanbul, 34010, Turkey (Türkiye)
08

References and documents

Publications

  • Funcke S, Pinnschmidt HO, Brinkmann C, Wesseler S, Beyer B, Fischer M, Nitzschke R. Nociception level-guided opioid administration in radical retropubic prostatectomy: a randomised controlled trial. Br J Anaesth. 2021 Feb;126(2):516-524. doi: 10.1016/j.bja.2020.09.051. Epub 2020 Nov 20. PubMed 33228979 ↗
  • Meijer FS, Martini CH, Broens S, Boon M, Niesters M, Aarts L, Olofsen E, van Velzen M, Dahan A. Nociception-guided versus Standard Care during Remifentanil-Propofol Anesthesia: A Randomized Controlled Trial. Anesthesiology. 2019 May;130(5):745-755. doi: 10.1097/ALN.0000000000002634. PubMed 30829658 ↗
  • Lumme A, Kalliomaki ML, Harju J, Nordstrom P. Combining Transversus Abdominis Plane and Rectus Sheath Blocks in Open Inguinal Hernia Surgery Anesthesia: A Retrospective Cohort Analysis. World J Surg. 2025 Mar;49(3):626-633. doi: 10.1002/wjs.12481. Epub 2025 Jan 23. PubMed 39853690 ↗
  • Cosarcan SK, Gurkan Y, Manici M, Ozdemir I, Kilic M, Esen T, Ercelen O. The effect of ultrasound-guided rectus sheath block on postoperative analgesia in robot assisted prostatectomy: A randomized controlled trial. Medicine (Baltimore). 2024 Apr 26;103(17):e37975. doi: 10.1097/MD.0000000000037975. PubMed 38669407 ↗
  • Lavand'homme P, Steyaert A. Opioid-free anesthesia opioid side effects: Tolerance and hyperalgesia. Best Pract Res Clin Anaesthesiol. 2017 Dec;31(4):487-498. doi: 10.1016/j.bpa.2017.05.003. Epub 2017 May 17. PubMed 29739537 ↗

Individual participant data

Plan to share: No — Individual participant data will not be publicly available. De-identified data may be shared upon reasonable request to the corresponding author, subject to institutional approval and a data use agreement.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2026 to primary completion in May 2026, 2 months.

Of 1,104 non-industry interventional studies with no phase under Prostatic Neoplasms, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 87. This study's 2 months is below that.

Counting every sponsor, half of 1,162 studies reached it within 43 months; a quarter within 22 and three quarters within 86.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 23, 2025
First posted
Feb 25, 2026
StartActual
Mar 15, 2026
Primary completionActual
May 15, 2026
CompletionActual
May 15, 2026
Last update
Aug 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07433140
Lead sponsor
Koc University Hospital
Responsible party
Rafet Onur Gorgulu (Rafet Onur Gorgulu, MD, Resident of Anesthesiology and Reanimation, Department of Anesthesiology, Koc University Hospital, Koc University Hospital) — Principal investigator
First posted
Feb 25, 2026
Start date
Mar 15, 2026
Primary completion
May 15, 2026
Completion
May 15, 2026
Last update
Aug 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion